Pharma-Bio Serv (PBSV) Accounts Payables (2010 - 2026)

Pharma-Bio Serv's Accounts Payables history runs 16 years deep, the most recent figure standing at $978541.0 for Q2 2026.

• Quarterly Accounts Payables rose 4.33% year-over-year to $978541.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $978541.0 (up 4.33% YoY) and the FY2025 annual result came in at $991169.0, down 12.1% from the prior year.
• Accounts Payables was $978541.0 for Q2 2026 at Pharma-Bio Serv, up from $869964.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $1.7 million in Q3 2022 and bottomed at $869964.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2024 — Accounts Payables sank 33.78% — and 2026, when it gained 4.33%.
• Pharma-Bio Serv's Accounts Payables stood at $1.6 million in 2022, then declined by 9.95% to $1.5 million in 2023, then retreated by 23.15% to $1.1 million in 2024, then decreased by 12.1% to $991169.0 in 2025, then slipped by 1.27% to $978541.0 in 2026.
• Business Quant data shows PBSV's Accounts Payables at $978541.0 in Q2 2026, $869964.0 in Q1 2026, and $991169.0 in Q4 2025.